The TME is heterogeneous because it is composed of diverse cellular and non-cellular components, each contributing differently to cancer progression. Factors such as genetic mutations, epigenetic changes, and metabolic variations within the cancer cells themselves further contribute to this heterogeneity. Additionally, the interactions between tumor cells and their surrounding microenvironment are dynamic and can change over time, adding another layer of complexity.
